Omicron BA. 1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

IT Lee, CA Cosgrove, P Moore, C Bethune… - The Lancet Infectious …, 2023 - thelancet.com
Background The omicron BA. 1 bivalent booster is used globally. Previous open-label
studies of the omicron BA. 1 (Moderna mRNA-1273.214) booster showed superior …

[HTML][HTML] Omicron BA. 1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

IT Lee, CA Cosgrove, P Moore, C Bethune… - The Lancet Infectious …, 2023 - thelancet.com
Background The omicron BA. 1 bivalent booster is used globally. Previous open-label
studies of the omicron BA. 1 (Moderna mRNA-1273.214) booster showed superior …

Omicron BA. 1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

IT Lee, CA Cosgrove, P Moore, C Bethune… - Lancet Infectious …, 2023 - eprints.ncl.ac.uk
Background: The omicron BA. 1 bivalent booster is used globally. Previous open-label
studies of the omicron BA. 1 (Moderna mRNA-1273.214) booster showed superior …

Omicron BA. 1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

IT Lee, CA Cosgrove, P Moore… - The Lancet …, 2023 - pubmed.ncbi.nlm.nih.gov
Background The omicron BA. 1 bivalent booster is used globally. Previous open-label
studies of the omicron BA. 1 (Moderna mRNA-1273.214) booster showed superior …

[HTML][HTML] Omicron BA. 1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

IT Lee, CA Cosgrove, P Moore… - The Lancet …, 2023 - eprints.whiterose.ac.uk
Background The omicron BA. 1 bivalent booster is used globally. Previous open-label
studies of the omicron BA. 1 (Moderna mRNA-1273.214) booster showed superior …

Omicron BA. 1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial.

IT Lee, CA Cosgrove, P Moore, C Bethune, R Nally… - 2023 - cabidigitallibrary.org
Background: The omicron BA. 1 bivalent booster is used globally. Previous open-label
studies of the omicron BA. 1 (Moderna mRNA-1273.214) booster showed superior …

Omicron BA. 1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

IT Lee, CA Cosgrove, P Moore, C Bethune… - The Lancet Infectious …, 2023 - orca.cardiff.ac.uk
Background The omicron BA. 1 bivalent booster is used globally. Previous open-label
studies of the omicron BA. 1 (Moderna mRNA-1273.214) booster showed superior …

Omicron BA. 1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

IT Lee, CA Cosgrove, P Moore, C Bethune… - The Lancet Infectious …, 2023 - Elsevier
Background The omicron BA. 1 bivalent booster is used globally. Previous open-label
studies of the omicron BA. 1 (Moderna mRNA-1273.214) booster showed superior …

[PDF][PDF] Omicron-BA. 1-containing mRNA-1273 boosters compared with the original vaccine in the 1 United Kingdom: a randomised, double-blind, active-control trial 2

IT Lee - core.ac.uk
Variant-containing bivalent booster vaccines comprised of mRNAs encoding the original
severe 74 acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Omicron BA. 1 or …

Omicron BA. 1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

IT Lee, CA Cosgrove, P Moore… - Lancet Infectious …, 2023 - discovery.ucl.ac.uk
BACKGROUND: The omicron BA. 1 bivalent booster is used globally. Previous open-label
studies of the omicron BA. 1 (Moderna mRNA-1273.214) booster showed superior …